Tidal Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tidal Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$746K	Buy	5,842 +1,816	+45%	+$227K	﹤0.01%	1646
2025 Q4	$491K	Sell	4,026 -4,854	-55%	-$557K	﹤0.01%	1653
2025 Q3	$890K	Buy	+8,880	New	+$800K	﹤0.01%	1269
2024 Q1	–	Sell	-4,134	Closed	-$369K	–	1755
2023 Q4	$369K	Buy	+4,134	New	+$307K	0.01%	1078

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tidal Investments's XBI Position: Q1 2026 in Review

Tidal Investments increased its State Street SPDR S&P Biotech ETF (XBI) stake by 45% in Q1 2026, buying an estimated $227K and bringing the position to 5,842 shares worth $746K. The position accounts for ﹤0.01% of the portfolio, ranked #1646.

Tidal Investments first reported a position in XBI in Q4 2023 and has held it in 4 quarters since. The position peaked at $890K in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Tidal Investments held 5,842 shares of State Street SPDR S&P Biotech ETF worth $746K as of Q1 2026.
Tidal Investments bought 1,816 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $227K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #1646 holding.
Tidal Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 4 quarters since.
Tidal Investments's State Street SPDR S&P Biotech ETF position peaked at $890K in Q3 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.